While S1P1 has a broad expression profile, S1P5 is expressed predominantly in brain tissues8; thus, a highly selective compound would afford more localized control over associated CNS disorders not affecting peripheral processes in the body. The gene discussed is S1PR5; the disease is central nervous system disorder.